| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.914 | 0.001 | 0.914 | Purinergic P2Y antagonist | 0.809 0.001 DBMET03170 0.704 0.001 DBMET03171 | ||
| 0.835 | 0.001 | 0.874 | Purinergic P2Y12 antagonist | 0.874 0.001 DBMET03170 0.869 0.001 DBMET03171 | DBMET03170 | |
| 0.83 | 0.004 | 0.863 | Platelet antagonist | 0.849 0.004 DBMET03170 0.863 0.004 DBMET03171 | DBMET03171 | |
| 0.781 | 0.001 | 0.873 | Purinergic P2T antagonist | 0.873 0.001 DBMET03170 0.817 0.001 DBMET03171 | DBMET03170 | |
| 0.74 | 0.003 | 0.757 | Platelet adhesion inhibitor | 0.743 0.003 DBMET03170 0.757 0.003 DBMET03171 | DBMET03171 | |
| 0.673 | 0.003 | 0.673 | Hemostatic | 0.599 0.003 DBMET03170 0.566 0.004 DBMET03171 | ||
| 0.662 | 0.005 | 0.693 | Platelet aggregation inhibitor | 0.674 0.005 DBMET03170 0.693 0.005 DBMET03171 | DBMET03171 | |
| 0.598 | 0.003 | 0.637 | Purinergic P2 antagonist | 0.637 0.003 DBMET03170 0.613 0.003 DBMET03171 | DBMET03170 | |
| 0.476 | 0.033 | 0.572 | Antithrombotic | 0.353 0.063 DBMET03170 0.572 0.019 DBMET03171 | DBMET03171 | |
| 0.43 | 0.004 | 0.43 | Cyclooxygenase 3 inhibitor | 0.236 0.01 DBMET03170 0.353 0.005 DBMET03171 | ||
| 0.361 | 0.115 | 0.361 | Cyclophilin D inhibitor | 0.299 0.163 DBMET03170 0.246 0.217 DBMET03171 | ||
| 0.309 | 0.109 | 0.409 | Immunosuppressant | 0.409 0.059 DBMET03171 | DBMET03171 | |
| 0.203 | 0.01 | 0.294 | Phosphodiesterase 7B inhibitor | 0.232 0.007 DBMET03170 0.294 0.004 DBMET03171 | DBMET03171 | |
| 0.141 | 0.004 | 0.186 | Phosphodiesterase VIII inhibitor | 0.151 0.003 DBMET03170 0.186 0.002 DBMET03171 | DBMET03171 | |
| 0.209 | 0.109 | 0.423 | DNA synthesis inhibitor | 0.189 0.14 DBMET03170 0.423 0.019 DBMET03171 | DBMET03171 | |
| 0.145 | 0.055 | 0.308 | Interleukin 4 antagonist | 0.137 0.063 DBMET03170 0.308 0.008 DBMET03171 | DBMET03171 | |
| 0.097 | 0.013 | 0.117 | Bombesin 3 receptor antagonist | 0.117 0.008 DBMET03170 | DBMET03170 | |
| 0.221 | 0.141 | 0.476 | Immunomodulator | 0.476 0.027 DBMET03171 | DBMET03171 | |
| 0.096 | 0.029 | 0.149 | Adenosine A3 receptor antagonist | 0.134 0.014 DBMET03170 0.149 0.013 DBMET03171 | DBMET03171 | |
| 0.078 | 0.013 | 0.117 | Lysine-specific demethylase 1A inhibitor | 0.117 0.005 DBMET03170 | DBMET03170 | |
| 0.147 | 0.084 | 0.166 | Thrombolytic | 0.119 0.112 DBMET03170 0.166 0.071 DBMET03171 | DBMET03171 | |
| 0.141 | 0.082 | 0.187 | NOS3 expression enhancer | 0.187 0.047 DBMET03170 | DBMET03170 | |
| 0.038 | 0.008 | 0.041 | Adenosine A1 receptor agonist | 0.041 0.007 DBMET03170 0.03 0.012 DBMET03171 | DBMET03170 | |
| 0.06 | 0.031 | 0.069 | Acetyl-CoA transferase 2 inhibitor | 0.064 0.024 DBMET03170 0.069 0.019 DBMET03171 | DBMET03171 | |
| 0.263 | 0.252 | 0.263 | Antiinflammatory | |||
| 0.054 | 0.045 | 0.127 | Adenosine A1 receptor antagonist | 0.099 0.023 DBMET03170 0.127 0.019 DBMET03171 | DBMET03171 | |
| 0.028 | 0.02 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.008 DBMET03171 | DBMET03171 | |
| 0.025 | 0.02 | 0.049 | Purinergic P2X agonist | 0.029 0.018 DBMET03170 0.049 0.01 DBMET03171 | DBMET03171 | |
| 0.016 | 0.015 | 0.019 | Adenosine A3 receptor agonist | 0.019 0.01 DBMET03170 0.016 0.014 DBMET03171 | DBMET03170 | |
| 0.193 | 0.202 | 0.261 | Interleukin 2 agonist | 0.261 0.107 DBMET03171 | DBMET03171 | |
| 0.012 | 0.022 | 0.024 | Adenosine A2 receptor agonist | 0.024 0.006 DBMET03171 | DBMET03171 | |
| 0.123 | 0.137 | 0.141 | MAP kinase kinase 4 inhibitor | 0.141 0.082 DBMET03170 | DBMET03170 | |
| 0.011 | 0.025 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 DBMET03171 | DBMET03171 | |
| 0.005 | 0.054 | 0.018 | Adenosine A2a receptor agonist | 0.018 0.009 DBMET03171 | DBMET03171 | |
| 0.097 | 0.162 | 0.239 | Angiogenesis stimulant | 0.239 0.075 DBMET03171 | DBMET03171 | |
| 0.026 | 0.11 | 0.082 | Adenosine A2a receptor antagonist | 0.082 0.03 DBMET03171 | DBMET03171 | |
| 0.006 | 0.144 | 0.027 | Purinergic P2Y1 agonist | 0.027 0.004 DBMET03171 | DBMET03171 | |
| 0.016 | 0.158 | 0.115 | Adenosine deaminase inhibitor | 0.115 0.004 DBMET03171 | DBMET03171 | |
| 0.019 | 0.163 | 0.062 | Adenosine A2 receptor antagonist | 0.062 0.046 DBMET03171 | DBMET03171 | |
| 0.012 | 0.158 | 0.094 | Antimetabolite | 0.094 0.017 DBMET03171 | DBMET03171 | |
| 0.035 | 0.186 | 0.207 | Interferon inducer | 0.207 0.003 DBMET03171 | DBMET03171 | |
| 0.09 | 0.241 | 0.408 | Immunostimulant | 0.408 0.047 DBMET03171 | DBMET03171 | |
| 0.05 | 0.228 | 0.091 | Interleukin 5 antagonist | 0.091 0.053 DBMET03171 | DBMET03171 | |
| 0.031 | 0.234 | 0.275 | Interferon agonist | 0.275 0.004 DBMET03171 | DBMET03171 | |
| 0.116 | 0.328 | 0.18 | Peptidyltransferase inhibitor | 0.18 0.129 DBMET03171 | DBMET03171 | |
| 0.069 | 0.484 | 0.271 | Antibacterial | 0.271 0.158 DBMET03171 | DBMET03171 | |
| 0.027 | 0.498 | 0.16 | Cell wall synthesis inhibitor | 0.16 0.057 DBMET03171 | DBMET03171 | |
| 0.003 | 0.495 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 DBMET03171 | DBMET03171 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |